International Urology and Nephrology

, Volume 32, Issue 2, pp 177–180 | Cite as

Hyperkalemia in hospitalized patients

  • Robert W. Dunlay
  • Marc S. Stevens


Objective: Evaluate the prevalence of hyperkalemia(potassium < 5.5 mmol/l) in hospitalized patientsnot on dialysis, as well as the association ofmedications, impaired renal function and comorbidconditions with hyperkalemia.Design: A retrospective case-control method.Setting: A tertiary care teaching hospital.Patients: Hyperkalemic adults not on dialysis withage and sex matched controls.Interventions: None.Main outcome measures: The use of medicationsassociated with hyperkalemia and renal function usinga calculated creatinine clearance were compared in thehyperkalemic and control groups.Results: 35 adult patients with hyperkalemia who werenot receiving dialysis were identified, with aprevalence in the hospitalized population of 3.3%.The hyperkalemic patients were older than the generalhospital population (p < 0.05). Compared withcontrols, hyperkalemic patients: had a lowercreatinine clearance (p < 0.05), were more likely tobe taking angiotensin-converting enzyme inhibitors (p < 0.05), and had an increased frequency of diabetesmellitus (p < 0.001). All of the control patientssurvived their hospitalization, but the mortality rate in the hyperkalemic group was 17% (p < 0.0001). Noneof the deaths were directly attributable to hyperkalemia.Conclusions: Hyperkalemia is more frequent in olderpatients and is usually mild. Hyperkalemia isassociated with diabetes mellitus, diminished renalfunction and the use of angiotensin-converting enzymeinhibitors. An elevated serum potassium level in ahospitalized patient may be a marker for asignificantly increased risk of death, which is due tounderlying medical problems and is not a consequenceof the hyperkalemia.

Angiotensin-converting enzyme inhibitors Hyperkalemia Potassium 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    DuBose TD. Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights. Kidney Int 1997; 51: 591–602.PubMedGoogle Scholar
  2. 2.
    Cohn JN. The management of chronic heart failure. N Engl J Med 1996; 335: 490–498.PubMedCrossRefGoogle Scholar
  3. 3.
    Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarctionevidence from clinical trials. N Engl J Med 1996; 335: 1660–1667.PubMedCrossRefGoogle Scholar
  4. 4.
    Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7: 1106–1122.PubMedGoogle Scholar
  5. 5.
    Levinsky, NG. Hyperkalemia. N Engl JMed 1966; 274: 1076–1077.CrossRefGoogle Scholar
  6. 6.
    Schlessman JJ. Sample size requirements in cohort and casecontrol studies of disease. Am J Epidem 1974; 99: 381–384.Google Scholar
  7. 7.
    Cockroft DW, Gault MH. Prediction of creatinine clearance from the serum creatinine. Nephron 1976; 16: 13–18.Google Scholar
  8. 8.
    Saggar-Malik AK, Cappuccio FP. Potassium supplements and potassium-sparing diuretics: A review and guide to appropriate use. Drugs 1993; 46: 986–1008.PubMedCrossRefGoogle Scholar
  9. 9.
    Ahmed EU, Mohammed BN, Matute R and Burns GC. Etiology of hyperkalemia in hospitalized patients: An answer to Harrington' question. J Am Soc Neph 1998; 9: 103A.Google Scholar
  10. 10.
    Rosa RM, Batlle D. Hyperkalemia. In: Jacobson HR, Striker GF, Klahr S, editors. The Principles and Practice of Nephrology. St Louis: Mosby-Year Book, 1995: 911–917.Google Scholar
  11. 11.
    Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. Arch Intern Med 1998; 158: 26–32.PubMedCrossRefGoogle Scholar
  12. 12.
    Mulkerrin E, Epstein FH, Clark BA. Aldosterone responses to hyperkalemia in healthy elderly humans. J Am Soc Nephrol 1995; 6: 1459–1462.PubMedGoogle Scholar
  13. 13.
    DeVita MV, Han H, Chan R, Zabetakis PM, Gleim GW, Michelis MF. Drug use and the elderly in relation to changing etiologies of hyperkalemia. Geriatric Nephrology Urology 1991; 1: 41–45.CrossRefGoogle Scholar
  14. 14.
    Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996; 334: 1649–1654.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Robert W. Dunlay
    • 1
  • Marc S. Stevens
    • 1
  1. 1.Departments of Medicine and PharmacologyCreighton UniversityOmahaUSA

Personalised recommendations